Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Morgan Stanley Maintains Equal-Weight on Endava, Maintains $40 Price Target

Author: Benzinga Newsdesk | April 22, 2024 01:20pm
Morgan Stanley analyst James Faucette maintains Endava (NYSE:DAVA) with a Equal-Weight and maintains $40 price target.

Posted In: DAVA

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist